Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Goldenwell Biotech Inc

GWLL ✓ COMPLIANT ☆ Track — members

OTC Markets · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$0.70

▲ +0.00%

Market Cap $69.30M · Vol 1.00K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$69.30M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

0.00

Momentum

Beta

N/A

vs Market

52W High

$10.00

93.00% below

52W Low

$0.39

250.00% above

Volume

1.00K

Avg 50

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

36.36%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Goldenwell Biotech Inc (GWLL) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does GWLL pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-9.09%

-22.22%

-29.65%

-33.33%

YTD

-75.86%

N/A

+180.00%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$60.00
Net Income	$-296,470.00
Revenue Growth (YoY)	-100.00%
Gross Margin	21.82%
Operating Margin	-206,047.27%
Net Profit Margin	-539,038.18%
ROE	N/A
ROA · ROIC	-227.78% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	5,220,000.00
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	99.00M

Technical Indicators

50-Day SMA	$0.75
200-Day SMA	$1.36
RSI (14)	0.00
Beta	N/A
52-Week High	$10.00
52-Week Low	$0.39

Volume Today	1.00K
Avg Daily Volume (30D)	50
Relative Volume	20.00x
Volatility (10D)	45.21
Volatility (30D)	51.08
Free Float	36.36%

Analyst Consensus

N/A

Current Price $0.70

Mean Target N/A

52W Low$0.39 52W High$10.00

Current

Target

$0.39 $10.00

Current Analyst target

· 0 analysts

Identifiers

ExchangeOTC Markets

FIGIBBG00RVG0Z48

ISINUS38138N1046

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG +1.02% ONC BeOne Medicines AG +1.18% RVMD Revolution Medicines Inc -0.09% 068270.KS Celltrion Inc -2.27% ABVX Abivax SA +1.53%

Company Profile

Goldenwell Biotech, Inc. is in the development stage whose purpose is research and development, production and sales health cares and supplements products. The Company is offering its products under two categories: Polypeptide Freeze-dried Powder and Solid Tablets Products. The Company’s products are JI MAI-Bovine Cardiac Vascular Active Peptide, Double Proline AG- three-dimensional (3D) Active Collagen Peptide, Cartilage Peptide-Type II collagen peptide, Se Plus, and Sugar Master. Bovine cardiac vascular active peptide is a protein peptide of vascular homology (amino acid type and its sequence) which made from healthy and fresh bovine cardiac vascular tissues as raw materials. Its DPAG product is designed to be an easily absorbed bioactive collagen. Type II collagen peptide is prepared from Bovine or Pig Cartilage bones by hot water extraction. Its Sugar Master product is made utilizing low temperature extraction techniques to maximize the harvest of bio-actives of plant matter.